His main research concerns Major histocompatibility complex, Cell biology, Mucosal associated invariant T cell, T-cell receptor and Immunology. His research in Major histocompatibility complex intersects with topics in Cytotoxic T cell, Monoclonal antibody and T cell. His Cytotoxic T cell research is multidisciplinary, relying on both Beta-2 microglobulin and Virology.
Ted H. Hansen combines subjects such as Tapasin, Gene expression, T lymphocyte and CTL* with his study of Cell biology. The concepts of his Mucosal associated invariant T cell study are interwoven with issues in Cell activation, Natural killer T cell and Antigen presentation. His T-cell receptor research is multidisciplinary, incorporating perspectives in Molecular biology, Interleukin 12, CD8 and Cancer research.
Ted H. Hansen mostly deals with Major histocompatibility complex, MHC class I, Molecular biology, Cell biology and Antigen. Ted H. Hansen has researched Major histocompatibility complex in several fields, including CD8, T-cell receptor, Cytotoxic T cell, Antigen presentation and Peptide. His MHC class I research incorporates themes from DNA vaccination and Recombinant DNA.
His work carried out in the field of Molecular biology brings together such families of science as Ligand, T cell, Mutant, Gene and Antibody. His studies deal with areas such as Endoplasmic-reticulum-associated protein degradation, Tapasin, T lymphocyte and Genetics as well as Cell biology. His Antigen research includes themes of Monoclonal antibody and Immune system.
Ted H. Hansen spends much of his time researching Major histocompatibility complex, Antigen, Molecular biology, Virology and Antigen presentation. His Major histocompatibility complex study introduces a deeper knowledge of Gene. His studies in Molecular biology integrate themes in fields like Cell, MHC class I, T-cell receptor and Antibody, Monoclonal antibody.
The study incorporates disciplines such as Biophysics and Peptide in addition to MHC class I. As a member of one scientific family, Ted H. Hansen mostly works in the field of T-cell receptor, focusing on CD8 and, on occasion, T cell and Cytotoxic T cell. Antigen presentation is closely attributed to Cell biology in his study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages
Emmanuel L Gautier;Tal Shay;Tal Shay;Jennifer Miller;Melanie Greter.
Nature Immunology (2012)
Licensing of natural killer cells by host major histocompatibility complex class I molecules
Sung Jin Kim;Jennifer Poursine-Laurent;Steven M. Truscott;Lonnie Lybarger.
Human Mucosal Associated Invariant T Cells Detect Bacterially Infected Cells
Marielle C. Gold;Marielle C. Gold;Stefania Cerri;Susan Smyk-Pearson;Meghan E. Cansler.
PLOS Biology (2010)
CD161 ++ CD8 + T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner
James E. Ussher;Matthew Bilton;Emma Attwod;Jonathan Shadwell.
European Journal of Immunology (2014)
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells
Rangsima Reantragoon;Alexandra Corbett;Isaac G Sakala;Nicholas A Gherardin;Nicholas A Gherardin.
Journal of Experimental Medicine (2013)
MHC class I antigen presentation: learning from viral evasion strategies
Ted H. Hansen;Marlene Bouvier.
Nature Reviews Immunology (2009)
Ubiquitination of serine, threonine, or lysine residues on the cytoplasmic tail can induce ERAD of MHC-I by viral E3 ligase mK3.
Xiaoli Wang;Roger A. Herr;Wei Jen Chua;Lonnie Lybarger.
Journal of Cell Biology (2007)
Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection.
Cormac Cosgrove;James E. Ussher;Andri Rauch;Kathleen Gärtner.
Bcl-2 is upregulated at the CD4^+ CD8^+ stage during positive selection and promotes thymocyte differentiation at several control points
Gerald P. Linette;Michael J. Grusby;Stephen M. Hedrick;Ted H. Hansen.
MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets
A Kurioka;J E Ussher;C Cosgrove;C Clough.
Mucosal Immunology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: